ovarian cancer

After losing her daughter Tanisa to ovarian cancer, Meenakshi Dhingra set up Tanisa Foundation to help improve cancer care in India -- something her daughter always wanted to do.

Dr Asima Mukhopadhyay is a clinical scientist and one of India's leading voices in women's cancer research. She is the co-developer of the PARP inhibitor Rucaparib, an anti-cancer drug, and has done groundbreaking research in the field of ovarian cancer.